Ventas, Inc. (VTR) Tops Q2 FFO by 3c; Lifts FY12 Guidance
Tweet
Share
E-mailGet Alerts VTR Hot Sheet
Price: $90.29 +1.44%
Financial Fact:
Medical office building services costs: 974K
Today's EPS Names:
CMCT, STEX, PWCM, More
Financial Fact:
Medical office building services costs: 974K
Today's EPS Names:
CMCT, STEX, PWCM, More
Join SI Premium – FREE
Ventas, Inc. (NYSE: VTR) reported Q2 FFO of $0.95, $0.03 better than the analyst estimate of $0.92. Revenue for the quarter came in at $616.45 million versus the consensus estimate of $591.93 million.
Sees FY2012 FFO of $3.70-$3.74, versus prior guidance of $3.63-$3.69 and the consensus of $3.72.
For earnings history and earnings-related data on Ventas, Inc. (VTR) click here.
Sees FY2012 FFO of $3.70-$3.74, versus prior guidance of $3.63-$3.69 and the consensus of $3.72.
For earnings history and earnings-related data on Ventas, Inc. (VTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
